Page last updated: 2024-11-03

probenecid and Fibroma, Shope

probenecid has been researched along with Fibroma, Shope in 4 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
"We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis."7.75Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. ( Castagnola, E; Cirillo, C; Cuzzubbo, D; Dallorso, S; Di Marco, E; Faraci, M; Lanino, E; Moroni, C; Morreale, G, 2009)
"62 mg/kg) both without and with oral probenecid in 9 transplant patients with persistent BK viremia without nephropathy in a crossover design."3.79Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. ( Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y, 2013)
"We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis."3.75Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. ( Castagnola, E; Cirillo, C; Cuzzubbo, D; Dallorso, S; Di Marco, E; Faraci, M; Lanino, E; Moroni, C; Morreale, G, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faraci, M1
Cuzzubbo, D1
Lanino, E1
Di Marco, E1
Cirillo, C1
Dallorso, S1
Morreale, G1
Moroni, C1
Castagnola, E1
Momper, JD1
Zhao, Y1
Shapiro, R1
Schonder, KS1
Gao, Y1
Randhawa, PS1
Venkataramanan, R1
Araya, CE1
Lew, JF1
Fennell, RS1
Neiberger, RE1
Dharnidharka, VR1
Barrios, C1
Puig, JM1
Mir, ML1

Other Studies

4 other studies available for probenecid and Fibroma, Shope

ArticleYear
Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant.
    The Pediatric infectious disease journal, 2009, Volume: 28, Issue:1

    Topics: Adolescent; Antiviral Agents; BK Virus; Child; Child, Preschool; Cidofovir; Cystitis; Cytosine; Drug

2009
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:1

    Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross

2013
Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Pediatric transplantation, 2006, Volume: 10, Issue:1

    Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Child; Cidofovir; Contraindications; Cytosine; DNA, Viral

2006
[Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2007, Volume: 27, Issue:6

    Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Drug Therapy, Combination; Humans; Kidney Tr

2007